Anti-Retroviral Tablets (ARV / HIV)

Our portfolio includes a wide range of **antiretroviral (ARV) tablets**, including high-demand single-ingredient and fixed-dose combinations used in HIV treatment programs worldwide. We focus on reliable, cost-effective generic formulations in internationally recognized strengths to support global healthcare, institutional procurement, and export markets. Dolutegravir + Lamivudine + Tenofovir Disoproxil Fumarate — 50 mg + 300 mg + 300 mg Lamivudine + Tenofovir Disoproxil Fumarate — 300 mg + 300 mg Emtricitabine + Tenofovir Disoproxil Fumarate — 200 mg + 300 mg Dolutegravir — 50 mg Dolutegravir + Emtricitabine + Tenofovir Alafenamide — 50 mg + 200 mg + 25 mg Abacavir + Lamivudine — 600 mg + 300 mg Lamivudine + Zidovudine — 150 mg + 300 mg Abacavir + Dolutegravir + Lamivudine — 600 mg + 50 mg + 300 mg Atazanavir + Ritonavir — 300 mg + 100 mg Lopinavir + Ritonavir — 200 mg + 50 mg *These are offered for markets where applicable patent and regulatory requirements have been fulf...